$930 million sale of Blue Bell biopharma firm finalized

The purchase price could grow if the Food and Drug Administration approves an experimental therapy that combines a product from each company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.